Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Nature Biotechnology|August 3, 1999
Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activityG Adlakha-Hutcheon, M B Bally, C R Shew, et al.
Thrombosis and Haemostasis|August 13, 1990
The binding of phosphatidylglycerol liposomes to rat platelets is mediated by complementH C Loughrey, M B Bally, L W Reinish, et al.
Canadian Journal of Biochemistry and Cell Biology = Revue Canadienne De Biochimie Et Biologie Cellulaire|June 1, 1983
Polymorphism of phosphatidylethanolamine-phosphatidylserine model systems: influence of cholesterol and Mg2+ on Ca2+-triggered bilayer to hexagonal (HII) transitionsM B Bally, C P Tilcock, M J Hope, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Studies on the myelosuppressive activity of doxorubicin entrapped in liposomesM B Bally, R Nayar, D Masin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Transfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumor-bearing miceM B Bally, D Masin, R Nayar, et al.
British Journal of Cancer|March 1, 1995
Pharmacology of liposomal vincristine in mice bearing L1210 ascitic and B16/BL6 solid tumoursL D Mayer, D Masin, R Nayar, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumorsH J Lim, D Masin, N L McIntosh, et al.
Pageof 11